Table 2.
Clinical characteristics of pancreatic adenocarcinoma patients with and without DM who underwent curative surgical resection.
| Variable | DM (N=275) | Non-DM (N=213) | Total (N=488) | p-value* |
|---|---|---|---|---|
| Age at time of pancreatic cancer diagnosis | 0.401 | |||
| Mean (SD) | 65.3 (10.6) | 64.4 (10.8) | 64.9 (10.7) | |
| Gender | 0.096 | |||
| Male | 150 (54.5%) | 100 (46.9%) | 250 (51.2%) | |
| Race | 717 | |||
| White/Caucasian | 269 (97.8%) | 209 (98.1%) | 478 (98.0%) | |
| Black/African-American | 3 (1.1%) | 1 (0.5%) | 4 (0.8%) | |
| Other | 3 (1.1%) | 3 (1.4%) | 6 (1.2%) | |
| Usual Adult BMI | <0.001 | |||
| Mean (SD) | 29.0 (5.7) | 26.8 (4.6) | 28.0 (5.4) | |
| Percent of Total Weight Lost | 0.332 | |||
| 0–10 | 126 (46.3%) | 93 (44.1%) | 219 (45.3%) | |
| 10–20 | 110 (40.4%) | 90 (42.7%) | 200 (41.4%) | |
| >20 | 36 (13.2%) | 28 (13.3%) | 64 (13.3%) | |
| Ever Smoker | 0.906 | |||
| Yes | 168 (61.1%) | 129 (60.6%) | 297 (60.9%) | |
| Packyears | 0.443 | |||
| None | 112 (41.8%) | 87 (42.9%) | 199 (42.3%) | |
| <10 | 32 (11.9%) | 32 (15.8%) | 64 (13.6%) | |
| 10–19 | 30 (11.2%) | 25 (12.3%) | 55 (11.7%) | |
| 20+ | 94 (35.1%) | 59 (29.1%) | 153 (32.5%) | |
| Performance score (Karnofsky) | 0.315 | |||
| <50 | 5 (1.9%) | 5 (2.6%) | 10 (2.2%) | |
| 60 | 23 (8.8%) | 16 (8.2%) | 39 (8.6%) | |
| 70 | 79 (30.4%) | 44 (22.7%) | 123 (27.1%) | |
| 80 | 61 (23.5%) | 59 (30.4%) | 120 (26.4%) | |
| 90–100 | 92 (35.4%) | 70 (36.1%) | 162 (35.7%) | |
| Family History of Diabetes | 0.046 | |||
| Yes | 158 (57.5%) | 103 (48.4%) | 261 (53.5%) |
*
P-values for categorical variables were calculated using a Pearson chi-square test. A Kruskal-Wallis test was used for continuous variables.